Literature DB >> 16203381

Reliability and validity of the Opiate Treatment Index among a sample of opioid users in the United Kingdom.

M Adelekan1, A Green, N Dasgupta, F Tallack, G V Stimson, B Wells.   

Abstract

To validate the Opiate Treatment Index (OTI) for use in the United Kingdom, 72 subjects attending two methadone clinics in London completed confidential interviews with two researchers at two points in time, 1-2 weeks apart. About half the interviews were conducted by the same interviewer on both occasions, and the remaining by different interviewers. These research designs enabled an estimation of the test-retest and inter-rater reliability of the instrument. Subjects' responses were validated against key worker reports and self-reported drug use against urinalysis results. The majority of the respondents were males (65%) and their mean age was 34.2 years (range 21-52; SD 8.5). Test-retest reliability coefficients were high for all the scales (range 0.77-0.86) in both the same and different interviewer situations. The internal reliability of the scales was generally high (Cronbach's alpha: range 0.34-0.93). The correlation with key workers' reports was high with the percentage agreement on the items ranging 74-100 (mean 87). The percentage agreement of self-reported drug use with urinalysis results was high (range 69-95; mean 89). These findings are similar to those obtained among Australian subjects and suggest a high cross-cultural validity for the OTI. Minor changes to the OTI have been incorporated into a modified version for use in the UK.

Entities:  

Year:  1996        PMID: 16203381     DOI: 10.1080/09595239600186001

Source DB:  PubMed          Journal:  Drug Alcohol Rev        ISSN: 0959-5236


  10 in total

1.  Inability to access addiction treatment and risk of HIV infection among injection drug users recruited from a supervised injection facility.

Authors:  M-J S Milloy; Thomas Kerr; Ruth Zhang; Mark Tyndall; Julio Montaner; Evan Wood
Journal:  J Public Health (Oxf)       Date:  2009-09-23       Impact factor: 2.341

2.  Predicting biopsychosocial outcomes for heroin users in primary care treatment: a prospective longitudinal cohort study.

Authors:  Jamie Parmenter; Caroline Mitchell; Jenny Keen; Phillip Oliver; Georgina Rowse; Isabel Neligan; Christopher Keil; Nigel Mathers
Journal:  Br J Gen Pract       Date:  2013-07       Impact factor: 5.386

3.  Psychosocial risk factors for inconsistent condom use in young people with first episode psychosis.

Authors:  Adrienne P Brown; Dan I Lubman; Susan J Paxton
Journal:  Community Ment Health J       Date:  2011-01-19

4.  Does methadone maintenance treatment based on the new national guidelines work in a primary care setting?

Authors:  Jenny Keen; Phillip Oliver; Georgina Rowse; Nigel Mathers
Journal:  Br J Gen Pract       Date:  2003-06       Impact factor: 5.386

5.  Methadone-mediated autonomic functioning of male patients with heroin dependence: the influence of borderline personality pattern.

Authors:  Wei-Lieh Huang; Yu-Hsuan Lin; Terry B J Kuo; Li-Ren Chang; Ying-Zai Chen; Cheryl C H Yang
Journal:  PLoS One       Date:  2012-05-22       Impact factor: 3.240

6.  Quantifying hepatitis C transmission risk using a new weighted scoring system for the Blood-Borne Virus Transmission Risk Assessment Questionnaire (BBV-TRAQ): applications for community-based HCV surveillance, education and prevention.

Authors:  Mark A Stoové; Craig L Fry; Nicholas Lintzeris
Journal:  Harm Reduct J       Date:  2008-04-23

7.  Low-dose add-on memantine treatment may improve cognitive performance and self-reported health conditions in opioid-dependent patients undergoing methadone-maintenance-therapy.

Authors:  Yun-Hsuan Chang; Shiou-Lan Chen; Sheng-Yu Lee; Po See Chen; Tzu-Yun Wang; I Hui Lee; Kao Chin Chen; Yen Kuang Yang; Jau-Shyong Hong; Ru-Band Lu
Journal:  Sci Rep       Date:  2015-05-19       Impact factor: 4.379

8.  Study protocol: a dose-escalating, phase-2 study of oral lisdexamfetamine in adults with methamphetamine dependence.

Authors:  Nadine Ezard; Adrian Dunlop; Brendan Clifford; Raimondo Bruno; Andrew Carr; Alexandra Bissaker; Nicholas Lintzeris
Journal:  BMC Psychiatry       Date:  2016-12-01       Impact factor: 3.630

9.  Safety and tolerability of oral lisdexamfetamine in adults with methamphetamine dependence: a phase-2 dose-escalation study.

Authors:  Nadine Ezard; Brendan Clifford; Adrian Dunlop; Raimondo Bruno; Andrew Carr; Zhixin Liu; Krista J Siefried; Nicholas Lintzeris
Journal:  BMJ Open       Date:  2021-05-18       Impact factor: 2.692

10.  Longitudinal Substance Use and Biopsychosocial Outcomes Following Therapeutic Community Treatment for Substance Dependence.

Authors:  Petra K Staiger; Paul Liknaitzky; Amelia J Lake; Stefan Gruenert
Journal:  J Clin Med       Date:  2020-01-01       Impact factor: 4.241

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.